Israel Englander’s Cardlytics CDLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-6,556
| Closed | -$68.8K | – | 5906 |
|
|
2026
Q1 | $68.8K | Sell |
6,556
-18,918
| -74% | -$185K | ﹤0.01% | 5394 |
|
|
2025
Q4 | $293K | Sell |
25,474
-12,402
| -33% | -$192K | ﹤0.01% | 5276 |
|
|
2025
Q3 | $920K | Sell |
37,876
-16,067
| -30% | -$268K | ﹤0.01% | 4688 |
|
|
2025
Q2 | $887K | Sell |
53,943
-16,621
| -24% | -$287K | ﹤0.01% | 4497 |
|
|
2025
Q1 | $1.28M | Buy |
70,564
+56,140
| +389% | +$1.6M | ﹤0.01% | 4161 |
|
|
2024
Q4 | $535K | Buy |
+14,424
| New | +$552K | ﹤0.01% | 4702 |
|
|
2024
Q2 | – | Sell |
-5,486
| Closed | -$795K | – | 5941 |
|
|
2024
Q1 | $795K | Sell |
5,486
-774
| -12% | -$65.4K | ﹤0.01% | 4496 |
|
|
2023
Q4 | $577K | Buy |
+6,260
| New | +$636K | ﹤0.01% | 4556 |
|
|
2023
Q3 | – | Sell |
-4,122
| Closed | -$260K | – | 6163 |
|
|
2023
Q2 | $260K | Buy |
+4,122
| New | +$250K | ﹤0.01% | 4984 |
|
|
2023
Q1 | – | Sell |
-3,904
| Closed | -$226K | – | 6408 |
|
|
2022
Q4 | $226K | Sell |
3,904
-9,062
| -70% | -$560K | ﹤0.01% | 5258 |
|
|
2022
Q3 | $1.22M | Buy |
12,966
+2,641
| +26% | +$376K | ﹤0.01% | 4171 |
|
|
2022
Q2 | $2.3M | Buy |
10,325
+9,114
| +753% | +$3.05M | ﹤0.01% | 3556 |
|
|
2022
Q1 | $666K | Buy |
1,211
+168
| +16% | +$102K | ﹤0.01% | 4890 |
|
|
2021
Q4 | $689K | Buy |
1,043
+303
| +41% | +$232K | ﹤0.01% | 4761 |
|
|
2021
Q3 | $621K | Sell |
740
-1,205
| -62% | -$1.22M | ﹤0.01% | 5149 |
|
|
2021
Q2 | $2.47M | Sell |
1,945
-1,325
| -41% | -$1.5M | ﹤0.01% | 3699 |
|
|
2021
Q1 | $3.59M | Buy |
3,270
+1,209
| +59% | +$1.6M | ﹤0.01% | 2952 |
|
|
2020
Q4 | $2.94M | Sell |
2,061
-5,304
| -72% | -$5.66M | ﹤0.01% | 2915 |
|
|
2020
Q3 | $5.2K | Buy |
+7,365
| New | +$5.35M | 0.01% | 1802 |
|
|
2020
Q2 | – | Sell |
-976
| Closed | -$341K | – | 4196 |
|
|
2020
Q1 | $341K | Sell |
976
-6,154
| -86% | -$4.36M | ﹤0.01% | 3102 |
|
|
2019
Q4 | $4.48M | Sell |
7,130
-11,641
| -62% | -$5.69M | 0.01% | 2026 |
|
|
2019
Q3 | $6.29M | Buy |
18,771
+12,160
| +184% | +$3.9M | 0.01% | 1620 |
|
|
2019
Q2 | $1.72M | Buy |
+6,611
| New | +$1.32M | ﹤0.01% | 2499 |
|
|
2018
Q4 | – | Sell |
-3,633
| Closed | -$910K | – | 3779 |
|
|
2018
Q3 | $910K | Sell |
3,633
-5,181
| -59% | -$1.11M | ﹤0.01% | 2919 |
|
|
2018
Q2 | $1.92M | Sell |
8,814
-8,876
| -50% | -$1.64M | ﹤0.01% | 2436 |
|
|
2018
Q1 | $2.59M | Buy |
+17,690
| New | +$2.99M | ﹤0.01% | 2171 |
|
Other funds holding CDLX
CIP
6CM
KGAMU
WPM
RC
QOP
Israel Englander's CDLX Position: Q2 2026 in Review
Israel Englander sold out of Cardlytics (CDLX) in Q2 2026, closing a stake of 6,556 shares — an estimated $68.8K sold.
Israel Englander first reported a position in CDLX in Q1 2018 and held it in 26 quarters. The position peaked at $6.29M in Q3 2019. 41 funds tracked by Wall St. Rank hold CDLX as of Q2 2026.
- Israel Englander reported no remaining Cardlytics position as of Q2 2026 after selling out during the quarter.
- Israel Englander sold 6,556 Cardlytics shares in Q2 2026, an estimated $68.8K.
- Israel Englander first reported a position in Cardlytics in Q1 2018 and held it in 26 quarters.
- Israel Englander's Cardlytics position peaked at $6.29M in Q3 2019.
- 41 funds tracked by Wall St. Rank held Cardlytics as of Q2 2026.
Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.